100 related articles for article (PubMed ID: 20850837)
1. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
[TBL] [Abstract][Full Text] [Related]
2. Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis.
Ryk C; Wiklund NP; Nyberg T; De Verdier PJ
Scand J Urol Nephrol; 2011 Nov; 45(5):319-25. PubMed ID: 21612325
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
4. The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.
Motallebipour M; Rada-Iglesias A; Jansson M; Wadelius C
Mol Vis; 2005 Nov; 11():950-7. PubMed ID: 16288199
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis.
Ryk C; de Verdier P; Montgomery E; Peter Wiklund N; Wiklund F; Grönberg H
Redox Biol; 2015 Aug; 5():419. PubMed ID: 28162285
[TBL] [Abstract][Full Text] [Related]
6. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
8. The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.
Ryk C; Hou SM; Pershagen G; Wiklund NP; Nyberg F; de Verdier PJ
Tumour Biol; 2014 May; 35(5):4425-34. PubMed ID: 24408018
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
Amasyali AS; Kucukgergin C; Erdem S; Sanli O; Seckin S; Nane I
J Urol; 2012 Dec; 188(6):2398-403. PubMed ID: 23088972
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.
Leung TF; Liu EK; Li CY; Chan IH; Yung E; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jul; 41(7):649-55. PubMed ID: 16703578
[TBL] [Abstract][Full Text] [Related]
11. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
[TBL] [Abstract][Full Text] [Related]
12. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.
Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K
J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390
[TBL] [Abstract][Full Text] [Related]
13. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
[TBL] [Abstract][Full Text] [Related]
14. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
[TBL] [Abstract][Full Text] [Related]
15. (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy.
Konno S; Hizawa N; Yamaguchi E; Jinushi E; Nishimura M
J Allergy Clin Immunol; 2001 Nov; 108(5):810-4. PubMed ID: 11692109
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM
Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870
[TBL] [Abstract][Full Text] [Related]
17. Association between achalasia and nitric oxide synthase gene polymorphisms.
Mearin F; García-González MA; Strunk M; Zárate N; Malagelada JR; Lanas A
Am J Gastroenterol; 2006 Sep; 101(9):1979-84. PubMed ID: 16848803
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.
Ryk C; Wiklund NP; Nyberg T; de Verdier PJ
Nitric Oxide; 2011 Oct; 25(3):338-43. PubMed ID: 21703358
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
[TBL] [Abstract][Full Text] [Related]
20. (CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study.
Pascual M; Sanz C; Isidoro-García M; Dávila I; Moreno E; Laffond E; Lorente F
J Investig Allergol Clin Immunol; 2008; 18(4):239-44. PubMed ID: 18714530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
